###begin article-title 0
###xml 22 31 22 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
New classification of HLA-DRB1 alleles in rheumatoid arthritis susceptibility: a combined analysis of worldwide samples
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 78 87 78 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 293 302 290 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 403 412 400 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 522 531 519 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 619 627 <span type="species:ncbi:9606">patients</span>
Rheumatoid arthritis (RA) is a complex polygenic disease of unknown etiology. HLA-DRB1 alleles encoding the shared epitope (SE) (RAA amino acid pattern in positions 72 to 74 of the third hypervariable region of the DRbeta1 chain) are associated with RA susceptibility. A new classification of HLA-DRB1 SE alleles has been developed by Tezenas du Montcel and colleagues to refine the association between HLA-DRB1 and RA. In the present study, we used RA samples collected worldwide to investigate the relevance of this new HLA-DRB1 classification in terms of RA susceptibility across various Caucasoid and non-Caucasoid patients.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 146 155 146 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 195 196 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 199 200 199 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 203 205 203 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D</sub>
###xml 208 210 208 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P</sub>
###xml 240 249 240 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 385 393 <span type="species:ncbi:9606">patients</span>
Eighteen subsamples were defined from a total number of 759 cases and 789 controls and grouped in 10 samples on the basis of their ethnic origin. HLA-DRB1 alleles were divided into five groups (S1, S2, S3D, S3P, and X) according to the new HLA-DRB1 allele classification. The whole analysis was performed by comparing carrier frequencies for the five HLA-DRB1 allele groups between RA patients and controls across the 10 Caucasoid and non-Caucasoid samples. The Mantel-Haenszel method of meta-analysis provided a global odds ratio (OR) estimate with 95% confidence interval (CI).
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 61 63 61 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 110 112 110 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 116 118 116 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
###xml 125 128 125 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
###xml 175 177 175 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 181 183 181 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
###xml 224 226 224 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 265 267 265 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 271 273 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-4</sup>
###xml 320 322 320 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 330 332 330 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3</sup>
###xml 387 390 387 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D </sub>
###xml 438 440 438 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 558 566 <span type="species:ncbi:9606">patients</span>
A positive association with RA susceptibility was found for S2 allele carriers (OR 2.15, 95% CI 1.54 to 3.00; p < 10-5) and S3P allele carriers (OR 2.74, 95% CI 2.01 to 3.74; p < 10-5). A negative association was found for S1 alleles (OR 0.60, 95% CI 0.48 to 0.76; p < 10-4) and X alleles (OR 0.58, 95% CI 0.39 to 0.84; p = 4 x 10-3). No significant association was highlighted for the S3D group of alleles (OR 0.89, 95% CI 0.69 to 1.14; p = 0.89). The complementary genotype analysis fit with the genotype risk hierarchy previously reported in Caucasoid RA patients.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 88 97 88 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 265 274 265 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 381 390 381 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
So far, the present study is the first attempt to investigate the relevance of this new HLA-DRB1 classification in terms of RA susceptibility on both Caucasoid and non-Caucasoid samples. Our results support the hypothesis of a differential role played by different HLA-DRB1 allele groups in RA susceptibility across different ethnic backgrounds and confirm the interest of such an HLA-DRB1 classification in differentiating predisposing and protective alleles.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 288 297 288 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 526 535 526 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 544 548 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 555 559 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 566 570 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 577 581 577 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 588 592 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 599 603 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 610 614 610 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 625 629 625 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 740 748 740 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DR&#946;1 </italic>
###xml 885 893 882 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 896 898 893 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1009 1010 1006 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1011 1012 1008 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
Rheumatoid arthritis (RA) is the most frequent chronic inflammatory rheumatic disease in the world, with prevalence estimates of 0.25% to 0.5%. Its pathogenesis is multifactorial and genetic factors may contribute for 40% to 60% of the total risk [1]. Among possible genetic factors, the HLA-DRB1 gene appears clearly associated with RA [2]. This association was first suggested more than 30 years ago [3] and was elaborated 10 years later by Gregersen and colleagues [4], who demonstrated that RA was associated with several HLA-DRB1 alleles (DRB1*0101, DRB1*0102, DRB1*0401, DRB1*0404, DRB1*0405, DRB1*0408, DRB1*1001, and DRB1*1402) encoding the RAA sequence of amino acids at positions 72 to 74 in the third hypervariable region of the DRbeta1 chain, known as the shared epitope (SE). Despite significant improvement in molecular biology techniques, association mechanisms between HLA-DRB1*SE+ alleles and RA remain debated and authors have demonstrated that each SE allele does not confer the same risk [4-6].
###end p 11
###begin p 12
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 95 104 95 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 400 409 400 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 419 420 419 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 423 424 423 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 427 429 427 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P</sub>
###xml 432 434 432 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D</sub>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 808 817 808 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
In a more recent study, Tezenas du Montcel and colleagues [8] advanced a new classification of HLA-DRB1 alleles, reconsidering the SE model in RA susceptibility. According to this new classification, the susceptibility to RA, which depends on whether the RAA sequence occupies positions 72 to 74, was modulated by the amino acids at positions 70 and 71, which led to the definition of five groups of HLA-DRB1 alleles: S1, S2, S3P, S3D, and X alleles. Michou and colleagues [9] tested and validated this new classification in an independent sample of 100 French Caucasoid RA trio families, providing estimates for the susceptibility risk genotypes. In the present study, we used worldwide RA samples from the 13th International Histocompatibility Working Group (IHWG) to investigate the relevance of this new HLA-DRB1 allele classification in terms of RA susceptibility across various Caucasoid and non-Caucasoid population samples.
###end p 12
###begin title 13
Materials and methods
###end title 13
###begin title 14
Selection process of case and control population samples
###end title 14
###begin p 15
###xml 409 410 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1091 1099 1091 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 1100 1109 1100 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DQB1 </italic>
###xml 1542 1543 1542 1543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
RA cases and healthy controls included in the present study were selected from a population of 2,376 individuals (1,210 cases and 1,166 controls), initially gathered by 19 laboratories in 17 countries in the framework of the 13th IHWG. The data are publicly available from the dbMHC (Major Histocompatibility Complex database) website of the National Center for Biotechnology Information (Bethesda, MD, USA) [7]. All RA cases met the following criteria: adult onset RA (by definition, 16 years of age or older) and the American College of Rheumatology criteria for RA [8]. For each laboratory, healthy controls were selected within the same geographical area as the RA cases. A selection procedure of cases and controls was carried out in order to allow the comparison of the data issued from the different laboratories that participated in the 13th IHWG: (a) cases and controls of undocumented origin were excluded, (b) samples consisting of cases without controls and samples of less than 20 individuals were discarded, and (c) cases and controls that were matched beforehand for specific HLA-DRB1-HLA-DQB1 haplotypes were excluded. Data from different submitters consisting of individuals from the same origin were pooled when no significant departures were found as assessed by an admixture test, which asymptotically follows a chi-square distribution with 1 degree of freedom. According to this selection procedure, 758 cases and 789 controls, issued from 10 different ethnic origin subsamples, were included in the present study (Table 1).
###end p 15
###begin p 16
Composition of the selected rheumatoid arthritis case and control population samples
###end p 16
###begin p 17
These data were extracted from the 13th International Histocompatibility Working Group rheumatoid arthritis samples and are available on the National Center for Biotechnology Information website [28]. For the sample selection procedure, please refer to the Materials and methods section of this article.
###end p 17
###begin title 18
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
HLA-DRB1 genotyping
###end title 18
###begin p 19
###xml 45 53 45 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 55 64 55 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
All RA cases and controls were genotyped for HLA-DRB1. HLA-DRB1 typing techniques used in the framework of the 13th IHWG are described extensively in the 13th IHWG Proceedings [9,10].
###end p 19
###begin title 20
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
HLA-DRB1 classification
###end title 20
###begin p 21
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 147 156 147 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 491 493 491 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 513 515 513 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 530 532 530 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 739 742 739 742 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D </sub>
###xml 757 760 757 760 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
HLA-DRB1 alleles were divided into five groups according to the classification proposed by Tezenas du Montcel and colleagues [11,12]. Briefly, the HLA-DRB1 alleles were first divided into two groups according to the presence or absence of the RAA sequence at positions 72 to 74 and were denoted S and X alleles, respectively. The S alleles were subsequently divided into three groups according to the amino acid (alanine [A], glutamic acid [E], lysine [K], or arginine [R]) at position 71: S1 for ARAA and ERAA, S2 for KRAA, and S3 for RRAA. Since an aspartic acid (D) at position 70 was reported to be protective against RA in contrast to a glutamine (Q) or an arginine (R) at the same position [13], two additional groups were defined: S3D for DRRAA and S3P for QRRAA or RRRAA [11,12].
###end p 21
###begin title 22
Statistical analysis
###end title 22
###begin p 23
###xml 107 108 107 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 111 112 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 115 117 115 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P</sub>
###xml 120 122 120 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D</sub>
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 491 500 491 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 565 573 <span type="species:ncbi:9606">patients</span>
To identify association with RA susceptibility, odds ratios (ORs) were calculated for the presence of the S1, S2, S3P, S3D, and X alleles. Confidence intervals (CIs) are given at 95% confidence. Consistently with previous findings [7-9] and with the main objective of this work (which is to challenge these previous findings in various Caucasoid and non-Caucasoid populations), we performed the whole analysis under a dominant effect model by comparing carrier frequencies for the different HLA-DRB1 allele groups defined according to the classification between RA patients and controls across the 10 Caucasoid and non-Caucasoid samples.
###end p 23
###begin p 24
###xml 636 638 636 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 704 706 704 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 976 978 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1057 1059 1057 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1082 1084 1082 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
We used a meta-analysis approach to combine the data issued from the different laboratories that participated in the 13th IHWG. The Mantel-Haenszel method assumes a fixed effect and combines studies using a method similar to inverse variance approaches to determine the weight given to each study. It provides a common OR estimate, taking into account the weight of the different samples and 95% CI. OR and 95% CI are shown on forest plots for each allele group studied. Statistical heterogeneity of the considered samples was assessed on the basis of the Q test (chi-square), using a significance level of 0.05, and reported with the I2 statistic (in which high values indicate high heterogeneity). An I2 value of greater than 50% was considered the threshold for heterogeneity. Genotype risk analyses were conducted using the same method. All computations were performed using the Revman 4.2.8 software package developed by the Nordic Cochrane Center (Copenhagen, Denmark) [14] and Stata version 7.0 software (StataCorp LP, College Station, TX, USA). All p values were two-sided. P values of less than 0.05 were considered significant, and corrections for multiple testing were mentioned when relevant.
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
###xml 37 46 37 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
Carrier frequencies of the different HLA-DRB1 allele groups in RA cases and controls for the various Caucasoid and non-Caucasoid population samples
###end title 26
###begin p 27
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 57 66 57 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 320 322 320 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 481 483 481 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 492 494 492 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 502 504 502 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3</sup>
###xml 563 565 563 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 567 569 567 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 575 577 575 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 587 589 587 589 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 591 593 591 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 602 604 602 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 614 617 614 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
###xml 619 621 619 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 630 632 630 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 645 648 645 648 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D </sub>
###xml 650 652 650 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 661 663 661 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 681 690 681 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
Figure 1 shows the carrier frequencies for the different HLA-DRB1 allele groups, as defined according to the classification developed by Tezenas du Montcel and colleagues [11], in cases and controls of each sample selected from the 13th IHWG. No significant departures from Hardy-Weinberg equilibrium were observed (all p > 0.05 after correction for multiple testing). Statistical testing for heterogeneity in the X allele group revealed a significant difference between samples (I2 = 62.9%, p = 4 x 10-3). No significant heterogeneity could be observed for the S1 (I2 = 0%, p = 0.57), S2 (I2 = 15.9%, p = 0.30), S3P (I2 = 19.5%, p = 0.27), or S3D (I2 = 23.6%, p = 0.23) groups of HLA-DRB1 alleles.
###end p 27
###begin p 28
###xml 848 850 848 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Carrier frequency comparisons of the different HLA-DRB1 allele groups between rheumatoid arthritis (RA) cases and controls across the various Caucasoid and non-Caucasoid population samples and overall effect estimation. This figure provides a summary meta-analysis of allele carrier frequencies according to HLA-DRB1 allele classification, in selected samples among the data available from the 13th International Histocompatibility Working Group on Rheumatoid Arthritis. For each population sample, odds ratios (ORs) and 95% confidence intervals (95% CIs) evaluate the significance of the association between the different HLA-DRB1 allele groups and RA susceptibility (blue boxes). The combined ORs and 95% CIs evaluate the significance of the global effect of the different HLA-DRB1 allele groups on RA susceptibility over all population samples. P values were calculated with the Mantel-Haenszel method (black diamonds).
###end p 28
###begin title 29
###xml 47 56 47 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
Carrier frequency comparisons of the different HLA-DRB1 allele groups between RA cases and controls across the various Caucasoid and non-Caucasoid population samples and overall effect estimation
###end title 29
###begin p 30
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 241 243 241 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 282 284 282 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 288 290 288 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
###xml 297 300 297 300 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
###xml 339 341 339 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 345 347 345 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
###xml 426 428 426 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 467 469 467 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 473 475 473 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-4</sup>
###xml 522 524 522 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 532 534 532 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3</sup>
###xml 606 609 606 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D </sub>
###xml 657 659 657 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 824 826 824 826 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 895 898 895 898 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D </sub>
###xml 944 945 944 945 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 974 976 974 976 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1025 1028 1025 1028 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
###xml 1083 1086 1083 1086 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D </sub>
###xml 1091 1093 1091 1093 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1113 1114 1113 1114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1177 1179 1177 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
Results of allele carrier frequency comparisons between RA cases and controls across the various Caucasoid and non-Caucasoid population samples are presented in Figure 1. An overall positive association with RA susceptibility was found for S2 alleles (OR 2.15, 95% CI 1.54 to 3.00; p < 10-5) and S3P alleles (OR 2.74, 95% CI 2.01 to 3.74; p < 10-5). An overall negative association with RA susceptibility was highlighted for S1 alleles (OR 0.60, 95% CI 0.48 to 0.76; p < 10-4) and X alleles (OR 0.58, 95% CI 0.39 to 0.84; p = 4 x 10-3). No significant association with RA susceptibility was found for the S3D group of alleles (OR 0.89, 95% CI 0.69 to 1.14; p = 0.88). In such an analysis, a potential bias may be introduced by the presence of allele adverse effect in the control group. For example, in the analysis of the S2 effect, the association may be overestimated due to the presence of S3D carriers in the control group (noncarrier of S2). Similarly, the effect of S2 may be underestimated thanks to the presence of S3P carriers. After controlling for the adverse effect of S3D and S1 in the analysis of S2, the association with RA susceptibility remained significant (p < 0.05).
###end p 30
###begin title 31
###xml 47 56 47 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
Carrier frequency comparisons of the different HLA-DRB1 allele groups between RA cases and controls in Caucasoid and non-Caucasoid population samples
###end title 31
###begin p 32
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 191 193 191 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 237 240 237 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
###xml 339 341 339 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 517 520 517 520 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
###xml 619 621 619 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Results of allele carrier frequency comparisons between RA cases and controls in Caucasoid and non-Caucasoid population samples are presented in Table 2. In the Caucasoid population sample, S2 alleles (OR 2.61, 95% CI 1.87 to 3.64) and S3P alleles (OR 1.86, 95% CI 1.39 to 2.49) were positively associated with RA susceptibility, whereas S1 alleles (OR 0.59, 95% CI 0.45 to 0.79) and X alleles (OR 0.74, 95% CI 0.56 to 0.96) were negatively associated with RA susceptibility. In the non-Caucasoid population sample, S3P alleles (OR 2.93, 95% CI 2.21 to 4.04) were positively associated with RA susceptibility, whereas S1 alleles (OR 0.52, 95% CI 0.37 to 0.71) and X alleles (OR 0.61, 95% CI 0.45 to 0.83) were negatively associated with RA susceptibility.
###end p 32
###begin p 33
Carrier frequency comparisons of the different HLA-DRB1 allele groups between rheumatoid arthritis cases and controls in Caucasoid and non-Caucasoid population samples
###end p 33
###begin p 34
The Caucasoid sample population refers to the combination of the following population samples: Greek, Spanish, Russian, and American (Whites). The non-Caucasoid sample population refers to the combination of the following population samples: North American (Amerinds), North American (Blacks), Bushmen, Korean, Chinese, and Javanese. The combined odds ratios (ORs) and 95% confidence intervals (CIs) evaluate the significance of the global effect of the different HLA-DRB1 allele groups on rheumatoid arthritis (RA) susceptibility in Caucasoids and non-Caucasoids.
###end p 34
###begin title 35
Overall effect estimation of genotypes resulting from the classification of HLA-DRB1 alleles on RA susceptibility
###end title 35
###begin p 36
###xml 54 55 54 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 111 112 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 115 117 115 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D</sub>
###xml 246 247 246 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 250 252 250 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P</sub>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 410 411 410 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 413 416 413 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
###xml 421 423 421 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P</sub>
###xml 425 428 425 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
###xml 581 582 581 582 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 584 585 584 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 588 589 588 589 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 598 600 598 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P</sub>
Using the approach proposed by Michou and colleagues [9], we further pooled the three low-risk allele groups (S1, S3D, and X), thus producing a new grouping called L alleles. Thus, in subsequent analyses, we considered only three allele groups (S2, S3P, and L alleles), with six corresponding genotypes [12]. The results of observed genotype distributions and of genotype relative risks are shown in Table 3. S2/S3P and S3P/S3P were associated with the greatest risks for RA, with ORs (95% CIs) of 7.25 (3.26 to 16.14) and 5.15 (2.91 to 9.12), respectively. These are followed by S2/S2, S2/L, and S3P/L, with ORs (95% CIs) of 4.95 (2.2 to 11.18), 2.41 (1.60 to 3.65), and 2.33 (1.57 to 3.45), respectively. These analyses were all performed using the L/L genotype as reference.
###end p 36
###begin p 37
Overall effect estimation of genotypes resulting from the classification of HLA-DRB1 alleles on rheumatoid arthritis susceptibility
###end p 37
###begin p 38
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 9 11 9 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P</sub>
###xml 14 16 14 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D</sub>
###xml 221 222 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 225 227 225 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D</sub>
###xml 329 330 329 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 333 335 333 335 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P</sub>
###xml 651 653 651 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
S1, S2, S3P, S3D, and X allele groups were defined according to the amino acid sequence at positions 70 to 74. According to the approach proposed by Michou and colleagues [9], we pooled the three low-risk allele groups (S1, S3D, and X), so called L alleles. Thus, in subsequent analyses, we considered only three allele groups (S2, S3P, and L alleles), with six corresponding genotypes [12]. The reference genotype is L/L. The combined odds ratios (ORs) and 95% confidence intervals (CIs) evaluate the significance of the global effect of the different HLA-DRB1 genotype groups on rheumatoid arthritis (RA) susceptibility over all population samples. P values were calculated with the Mantel-Haenszel method.
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 89 98 89 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 488 490 488 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 495 498 495 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
###xml 570 572 570 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
In the present association study, we investigated the relevance of the classification of HLA-DRB1 alleles proposed by Tezenas du Montcel and colleagues [11] regarding susceptibility to RA, across various Caucasoid and non-Caucasoid population samples, using publicly available data from the 13th IHWG RA studies. Across these various population samples, our approach strengthens the relevance of this classification, exhibiting an overall positive association with RA susceptibility for S2 and S3P alleles and an overall negative association with RA susceptibility for S1 and X alleles. The genotype analysis performed in the present study fits with the genotype risk hierarchy previously reported in Caucasoid RA sporadic cases [11] and families [12].
###end p 40
###begin p 41
###xml 145 146 145 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 149 150 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 153 156 153 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D </sub>
###xml 161 164 161 164 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
###xml 379 388 379 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 702 711 702 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 896 897 896 897 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 900 901 900 901 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 904 907 904 907 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D </sub>
###xml 912 915 912 915 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
###xml 1199 1200 1199 1200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1203 1204 1203 1204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1207 1210 1207 1210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3D </sub>
###xml 1215 1218 1215 1218 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
The present combined analysis included 10 samples from different genetic backgrounds. Although we did not observe significant heterogeneity for S1, S2, S3D and S3P allele groups, we observed significant heterogeneity for the X allele group across the different population samples. The fixed effect model of the Mantel-Haenszel method, used for the overall effect analysis of the HLA-DRB1 allele and genotype groups on RA susceptibility in the present study, assumes that each allele group carries out a homogeneous effect on RA susceptibility across the various Caucasoid and non-Caucasoid samples. The heterogeneity observed for the X allele group may be questioned according the heterogeneity of the HLA-DRB1 allele and genotype groups at two levels across the different population samples: the effect level and the frequency level. Our data suggest that there is a differential effect of the S1, S2, S3D and S3P allele groups on RA susceptibility. Each of these effects seems homogenous across the various population samples. Because the SE allele distribution varies across these populations, the resulting effect of the X allele group on RA susceptibility depends both on the frequency of the S1, S2, S3D and S3P allele groups, and their respective effects on RA susceptibility, which might explain the observed heterogeneity of the effect of the X allele group in our study.
###end p 41
###begin p 42
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1055 1057 1055 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1321 1323 1321 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1324 1326 1324 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1663 1665 1663 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1666 1668 1666 1668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1758 1760 1758 1760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1761 1763 1761 1763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1803 1805 1803 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1886 1894 1886 1894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 174 182 <span type="species:ncbi:9606">patients</span>
###xml 508 511 <span type="species:ncbi:9606">men</span>
###xml 535 540 <span type="species:ncbi:9606">women</span>
###xml 560 566 <span type="species:ncbi:9606">people</span>
The contribution of SE alleles to RA susceptibility has been confirmed by numerous studies on different populations. For example, a recent meta-analysis on Latin American RA patients has shown the important role played by SE in RA susceptibility [15]. However, RA prevalence studies have shown differences in frequency estimations between populations with different genetic backgrounds. The highest prevalence rates have been found in Native American populations with estimation ranges of 32 to 48 per 1,000 men and 59 to 70 per 1,000 women. In Afro-Caribbean people who live in the UK, RA prevalence appeared to be lower than that in the general population. In urban African populations, RA prevalence was estimated around 10 per 1,000 and was found to be significantly higher than in rural populations. Studies on Chinese populations have reported lower prevalence estimations than in European ones. Molokhia and McKeigue previously pointed out the difficulty brought up by admixture in investigating the etiology of rheumatic diseases, notably for RA [16]. The significant variations observed in the incidence and prevalence of RA among different populations or ethnic groups could be explained, in part, by genetic variations in the HLA region, especially variations in the prevalence of SE in different populations [17,18]. In addition, as no consideration of environmental exposure variations between the population samples studied was made, the heterogeneity could be explained by the different impact of environmental factors on RA susceptibility in each different sample, such as nutrition as previously suggested, in particular in the Greek population [18,19]. In addition to nutrition, environmental factors such as exposure to cigarette smoking [20,21] or individual factors such as gender [22] may influence susceptibility to RA by interacting with genetic factors such as HLA-DRB1.
###end p 42
###begin p 43
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 339 347 339 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 567 575 567 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
The classification proposed by Tezenas du Montcel and colleagues [11], based on amino acid sequence at positions 70 to 74, does not aim to account for all previously reported associations between particular HLA-DRB1 alleles and RA susceptibility in specific ethnic backgrounds. For example, the previously reported association between the HLA-DRB1*0901 allele and RA susceptibility in East Asian populations could not be tested in the present study, as this particular allele was classified together with many others as an X allele [23-25]. The high frequency of the HLA-DRB1*0901 allele in the Javanese population could contribute both to the association found between X alleles and susceptibility to RA in this particular population sample and to the observed heterogeneity of the X allele group.
###end p 43
###begin p 44
###xml 24 33 24 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 105 114 105 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 565 566 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 291 296 <span type="species:ncbi:9606">human</span>
The contribution of the HLA-DRB1 allele classification in accounting for the genetic contribution of the HLA-DRB1 gene was previously analyzed in terms of RA severity and in terms of autoantibody production such as anti-cyclic citrullinated peptide (anti-CCP) antibodies and anti-deiminated human fibrinogen autoantibodies. As RA severity outcomes as well as anti-CPP information were not collected in the framework of the 13th IHWG, we were not able to discuss the relevance of the classification of HLA-DRB1 alleles proposed by Tezenas du Montcel and colleagues [8] regarding RA severity or autoantibody production in the various Caucasoid and non-Caucasoid population samples included in the present study.
###end p 44
###begin title 45
Conclusion
###end title 45
###begin p 46
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 299 301 299 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 306 309 306 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3P </sub>
###xml 547 555 <span type="species:ncbi:9606">patients</span>
Across these various samples coming from both Caucasoid and non-Caucasoid populations, we investigated the relevance of the classification of HLA-DRB1 alleles proposed by Tezenas du Montcel and colleagues [11] regarding susceptibility to RA. We confirm previous findings on the contribution of the S2 and S3P risk allele groups to RA susceptibility. In spite of the small sample size in some ethnic groups, the present study allows the differentiation between predisposing and protective HLA-DRB1 SE alleles in both Caucasoid and non-Caucasoid RA patients.
###end p 46
###begin p 47
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 886 888 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 727 735 <span type="species:ncbi:9606">patients</span>
This report also emphasized the very crucial importance of public release of large-scale study data in genetic epidemiology. The need for large samples to refine the study of effects of modest magnitude and the necessity to replicate studies across different ethnic backgrounds rely on easy access to a large variety of data organized in a systematic way. After an initial period of restricted use of the data by the initial investigators, the access to clinical and genetic anonymous individual data should be made possible; this is the current policy of the National Institutes of Health (Bethesda, MD, USA) for genome-wide association study results [26]. Combined with a detailed description of the sampling scheme for both patients and controls, advanced statistical analysis will contribute to enhance secondary uses of data valorizing the efforts of previously completed studies [27].
###end p 47
###begin title 48
Abbreviations
###end title 48
###begin p 49
Anti-CCP = anti-cyclic citrullinated peptide; CI = confidence interval; IHWG = International Histocompatibility Working Group; OR = odds ratio; RA = rheumatoid arthritis; SE = shared epitope.
###end p 49
###begin title 50
Competing interests
###end title 50
###begin p 51
The authors declare that they have no competing interests.
###end p 51
###begin title 52
Authors' contributions
###end title 52
###begin p 53
TB, ACo, and P-AG took the leadership of the study in both immunological and statistical aspects. ACa contributed through the assessment of clinical aspects. AC-T contributed to the statistical analysis. All authors read and approved the final manuscript.
###end p 53
###begin title 54
Acknowledgements
###end title 54
###begin p 55
###xml 500 508 <span type="species:ncbi:9606">patients</span>
The authors wish to gratefully acknowledge the contributions of John Hansen and Lee Nelson at the Fred Hutchinson Cancer Research Center (Seattle, WA, USA) and Mike Feolo and the dbMHC (major histocompatibility complex database) team at the National Center for Biotechnology Information (Bethesda, MD, USA) and the help of technical and clinical collaborators from the rheumatoid arthritis international working group, for clinical data management and laboratory typings. The authors are indebted to patients and controls for their kind participation. All of these contributions were invaluable for the setting up of the database used in this article. Infrastructures and facilities from Institut National de la Sante et de la recherche medicale Inserm, Unit 558, Toulouse, and from University Paul Sabatier Toulouse III were used, in particular the TIERSMIP platform for managing multi-site clinical research data management and analysis. The authors were supported by the following institutions: Institut National de la Sante et de la recherche medicale: INSERM, Unit 558, Toulouse, France (P-AG, AC-T, and AC); Centre National de la Recherche Scientifique (AC-T); Department of Rheumatology (AC); Department of Epidemiology (P-AG); and University Hospital, Bordeaux (TB).
###end p 55
###begin article-title 56
Twin concordance rates for rheumatoid arthritis: results from a nationwide study
###end article-title 56
###begin article-title 57
A review of the MHC genetics of rheumatoid arthritis
###end article-title 57
###begin article-title 58
Mixed lymphocyte cultures in rheumatoid arthritis
###end article-title 58
###begin article-title 59
The Influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis
###end article-title 59
###begin article-title 60
Modelling the major histocompatibility complex susceptibility to RA using the MASC method
###end article-title 60
###begin article-title 61
Modeling the HLA component in rheumatoid arthritis: sensitivity to DRB1 allele frequencies
###end article-title 61
###begin article-title 62
Database resources of the National Center for Biotechnology Information
###end article-title 62
###begin article-title 63
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
###end article-title 63
###begin article-title 64
New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility
###end article-title 64
###begin article-title 65
Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis
###end article-title 65
###begin article-title 66
HLA class II association with rheumatoid arthritis: facts and interpretations
###end article-title 66
###begin article-title 67
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Meta-analysis of HLA-DRB1 polymorphism in Latin American patients with rheumatoid arthritis
###end article-title 67
###begin article-title 68
Risk for rheumatic disease in relation to ethnicity and admixture
###end article-title 68
###begin article-title 69
###xml 114 122 <span type="species:ncbi:9606">patients</span>
Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients
###end article-title 69
###begin article-title 70
Shared epitopes and rheumatoid arthritis: disease associations in Greece and meta-analysis of Mediterranean European populations
###end article-title 70
###begin article-title 71
Dietary factors in relation to rheumatoid arthritis: a role for olive oil and cooked vegetables?
###end article-title 71
###begin article-title 72
A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis
###end article-title 72
###begin article-title 73
Smoking and HLA-DR shared epitope alleles in rheumatoid arthritis: comment on the article by Padyukov et al
###end article-title 73
###begin article-title 74
Sex influences on the penetrance of HLA shared-epitope genotypes for rheumatoid arthritis
###end article-title 74
###begin article-title 75
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences
###end article-title 75
###begin article-title 76
Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1*0405 and *0901
###end article-title 76
###begin article-title 77
The homozygote of HLA-DRB1* not its heterozygote, is associated with rheumatoid arthritis in Japanese
###end article-title 77
###begin article-title 78
Fact Sheet on Genome Wide Association Studies (GWAS) proposed policy
###end article-title 78
###begin article-title 79
Replicating genotype-phenotype associations
###end article-title 79
###begin article-title 80
National Center for Biotechnology Information website
###end article-title 80

